Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2026
Reporting Period: Single event date (July 23, 2026)
Business Context: The Company is a Delaware corporation with principal executive offices in New York, NY. It is listed on The Nasdaq Stock Market LLC under the symbol "INBS".
Key Financial Metrics
This filing is a current report regarding a regulatory milestone and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change reported is a regulatory development rather than a financial one. On July 23, 2026, the Company announced it has addressed all cybersecurity and software-related review items required for its upcoming FDA 510(k) submission.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) confirming the resolution of specific review items for its FDA submission. The disclosure is qualified in its entirety by the full text of the press release.
Risks and Contingencies: The filing notes that the information provided is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and is not incorporated by reference unless specifically identified. No specific financial risks or contingencies are detailed in this text.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for details on the FDA 510(k) submission timeline.
- Confirm the status of the FDA review process following the resolution of cybersecurity and software items.
- Review subsequent filings for any financial impact related to the regulatory milestone.
- Check for any updates on the Company's cash position or funding needs, as this 8-K does not provide liquidity data.